Skip to content
WeighLab
Menu
Ranked #377 · Grade C

Mojoon review

Mojoon is a bilingual (Chinese/English) DTC telehealth platform selling compounded injectable and oral semaglutide, LegitScript-claimed and licensed across 48 states (excluding New Mexico and Mississippi).

Visit Mojoon Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. See our disclosure.
Semaglutide
$350/mo (0.25 mg dose, compounded)
Tirzepatide
Not disclosed
Coverage
Coverage not published
Brand-name
Compounded only

Semaglutide · modeled / year

$4,200

Pricing verified August 2026

The Index scorecard

Mojoon scored on our six Cost-Efficiency Index factors. See the methodology.

Normalized Cost/Month35/100
Price Transparency78/100
Nationwide Access24/100
Formulation Options64/100
Clinical Oversight74/100
Contract Flexibility55/100

Where the value is

  • Publishes an actual price range ($350-$520/treatment) rather than a single vague 'starting at' figure, and explains why the price rises (monthly dose escalation from 0.25 mg to 2.4 mg)
  • Claims LegitScript certification, and pharmacy licensure across all 50 states for dispensing even though provider coverage is 48 states
  • No long-term contract or hidden fees claimed on the product page
  • Bilingual site (Simplified Chinese, Traditional Chinese, English) with a working /en/ mirror, unusual outreach to Chinese-speaking US patients

The tradeoffs

  • The site's own prominent marketing figure ('$450 per month') is HIGHER than its own disclosed starting-dose floor ($350) — the headline number is not the entry price
  • Tirzepatide is listed as an offered treatment in the navigation but its dedicated page carries no pricing at all
  • No LegitScript certificate number, no named medical director, and no named compounding pharmacy anywhere on the site — only generic 'licensed medical team' language
  • Not available in New Mexico or Mississippi despite the 48-state licensed-pharmacy claim

The bottom line

Best for: Shoppers comfortable reading past a marketing headline to a lower published starting-dose price. Mojoon is a bilingual (Chinese/English) DTC telehealth platform selling compounded injectable and oral semaglutide, LegitScript-claimed and licensed across 48 states (excluding New Mexico and Mississippi).

Ranked #377 of 539 providers on the Cost-Efficiency Index — see our #1 pick, CoreAge Rx, for comparison.

Compare with other providers

All 538 other providers we've modeled, in Cost-Efficiency Index order. See the ranked alternatives to Mojoon.

The 18 programs nearest this one

Pricing, states and verification reflect Mojoon's public disclosures at last review; the Cost-Efficiency Index is our editorial judgment per the methodology. Prices change — confirm on Mojoon's site. Not medical advice; see our disclosure.

← Back to the value leaderboard